Cytomegalovirus (CMV) is an important cause of morbidity and mortality in transplant patients, and is typically monitored using laboratory-developed quantitative molecular assays. Clinicians who use ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing authorization to Meridian Bioscience Inc. for the Alethia CMV Assay Test System to aid ...

KANSAS CITY, Mo.--(BUSINESS WIRE)--ViraCor Laboratories, the leader in molecular diagnostic testing for infectious diseases, today announced the launch of a new cytomegalovirus (CMV) antiviral ...

PITTSBURGH--(BUSINESS WIRE)--Plexision, a biotechnology company, is offering the first blood test panel capable of reporting the risk of cytomegalovirus infection and transplant rejection within six ...

Cytomegalovirus (CMV) is one of the most common human herpesviruses, infecting nearly half of the adult population in the US. Vertical transmission can occur during pregnancy, and congenital CMV ...

With no vaccine available, early detection, hygiene practices, and public education are vital to prevent long-term disabilities caused by Human Cytomegalovirus in Kashmir’s children Dr Umer Majeed ...